Skip to content

An observational study of the effect of repetitive transcranial magnetic stimulation on insomnia patients

An observational study of the effect of repetitive transcranial magnetic stimulation on insomnia patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400092312
Enrollment
Unknown
Registered
2024-11-14
Start date
2024-12-01
Completion date
Unknown
Last updated
2024-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insomnia disorder

Interventions

Insomnia disorder group:None
healthy control group:none

Sponsors

The Second Hospital of Hebei Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patient group inclusion criteria: 1.1. Aged 18-80 years old; 1.2. meet the diagnostic criteria for insomnia disorder in the DSM-5; 1.3.PSQI total score >5; 1.4. Patients who were treated with repeated transcranial magnetic stimulation in our hospital for insomnia for 4 weeks from January 2020 to January 2024 and underwent PSQI, ISI, BDI, BAI, PSG and EEG examinations before and after treatment were selected. 2. Inclusion criteria of healthy control group: 2.1. Aged 18-80 years old; 2.2. No symptoms or history of mental disorders and sleep disorders; 2.3. Total score of PSQI is less than or equal to 5; 2.4. Have not taken psychotropic drugs or hypnotic drugs; 2.5 Physical examination was performed in our hospital, including PSQI, ISI, BDI, BAI, PSG, EEG.

Exclusion criteria

Exclusion criteria: 3. Exclusion criteria (Those who meet one of the following items cannot be included in the group) 3.1. suffering from a serious medical disease; 3.2 Patients with schizophrenia, schizoaffective disorder, persistent delusional disorder (paranoid psychosis), bipolar disorder, mental disorders caused by epilepsy, mental disorders accompanied by mental retardation, organic mental disorders; 3.3. Patients with major depressive disorder and suicidal tendencies; 3.4. Patients who have received electroconvulsive therapy, transcranial magnetic stimulation or transcranial direct current stimulation within the last 3 months; 3.5. Patients with cochlear implants, cardiac pacemakers, or metal implants in the brain; 3.6. Have a history of epilepsy.

Design outcomes

Primary

MeasureTime frame
Resting-state electroencephalogram (EEG);polysomnography (PSG);Pittsburgh Sleep Quality Index;Insomnia Severity Index;

Secondary

MeasureTime frame
Beck Depression Inventory;Beck Anxiety Inventory;Mini-Mental State Examination;MoCA;

Countries

China

Contacts

Public ContactYuan Kai; Zhao Xumeng

School of Life Science and Technology, Xidian University; The Second Hospital of Hebei Medical University

kyuan@xidian.edu.cn+86 180 6689 8052

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026